Genotoxic effects of base and prime editing in human hematopoietic stem cells

Martina Fiumara(Vita-Salute San Raffaele University), Samuele Ferrari(Vita-Salute San Raffaele University), Attya Omer(The San Raffaele Telethon Institute for Gene Therapy), Stefano Beretta(The San Raffaele Telethon Institute for Gene Therapy), Luisa Albano(The San Raffaele Telethon Institute for Gene Therapy), Daniele Canarutto(Vita-Salute San Raffaele University), Angelica Varesi(The San Raffaele Telethon Institute for Gene Therapy), Chiara Gaddoni(The San Raffaele Telethon Institute for Gene Therapy), Chiara Brombin(Vita-Salute San Raffaele University), Federica Cugnata(Vita-Salute San Raffaele University), Erika Zonari(The San Raffaele Telethon Institute for Gene Therapy), Matteo Maria Naldini(The San Raffaele Telethon Institute for Gene Therapy), Matteo Barcella(The San Raffaele Telethon Institute for Gene Therapy), Bernhard Gentner(The San Raffaele Telethon Institute for Gene Therapy), Ivan Merelli(The San Raffaele Telethon Institute for Gene Therapy), Luigi Naldini(Vita-Salute San Raffaele University)
Nature Biotechnology
September 7, 2023
Cited by 212Open Access
Full Text

Abstract

Base and prime editors (BEs and PEs) may provide more precise genetic engineering than nuclease-based approaches because they bypass the dependence on DNA double-strand breaks. However, little is known about their cellular responses and genotoxicity. Here, we compared state-of-the-art BEs and PEs and Cas9 in human hematopoietic stem and progenitor cells with respect to editing efficiency, cytotoxicity, transcriptomic changes and on-target and genome-wide genotoxicity. BEs and PEs induced detrimental transcriptional responses that reduced editing efficiency and hematopoietic repopulation in xenotransplants and also generated DNA double-strand breaks and genotoxic byproducts, including deletions and translocations, at a lower frequency than Cas9. These effects were strongest for cytidine BEs due to suboptimal inhibition of base excision repair and were mitigated by tailoring delivery timing and editor expression through optimized mRNA design. However, BEs altered the mutational landscape of hematopoietic stem and progenitor cells across the genome by increasing the load and relative proportions of nucleotide variants. These findings raise concerns about the genotoxicity of BEs and PEs and warrant further investigation in view of their clinical application.


Related Papers